Experienced healthcare lawyers advise doctors, physicians, and medical practices or a full range of regulatory and compliance issues including HIPAA, Stark Law, and the AKS.
The DOJ reported several new cases in which health care companies and doctors agreed to pay millions to settle claims of healthcare fraud due to AKS and Stark violations.
AI in the healthcare industry almost by definition, requires constant access to patient information. Developers and covered health providers need to understand when and how HIPAA applies to their [...]
Jill’s healthcare venture requires her to source a medical doctor (MD) who can collaborate with Jill’s startup to provide a series of innovative healthcare therapies to users
The Federal Trade Commission (FTC) and Federal Drug Administration (FDA) are continuing to send warning letters to companies that promise treatments and cures for COVID-19
Doctors, medical practices, and health businesses in California need to be aware of the relevant federal and state laws that regulate their practice and industry – including those on the CHHS website.
Medical providers and healthcare companies need to know numerous rules that govern the products and services the providers offer. Health providers need to pay special attention to the needs of [...]
Federal Trade Commission is sending warning letters after reviewing company websites, social media, and marketing materials for unsubstantiated claims that therapies can prevent, or cure COVID-19.
The FDA has a new proposal for approving AI and ML software that looks at the total product lifecycle from development to post-market uses and the adaptations the software learns
The Federal Trade Commission sent 45 more warning letters to businesses for falsely claiming their supplements, herbs, and other products and therapies could prevent to treat COVID-19
The California Consumer Privacy Act Affects the Healthcare Industry goes into effect on January 1, 2020. Failure to comply with the data protection requirements can result in fines and penalties.
More FDA answers to questions about cannabis-derived CBD drugs, foods, dietary supplements and food products including access to CBD for clinical investigations.
As more artificial intelligence products become available, the FDA is reevaluating its approval criteria. For now, De novo approval and 501(k) are being used along with premarket approval.
Federal Drug Administration continues to send warning letters to companies that boast products can treat, diagnose, prevent, or cure COVID-19 or boost immunity.
Physician recruitment agreements involve the rights and duties of three parties. Experienced healthcare lawyers craft the proper exceptions to the Anti-Kickback Statute and Stark Law
Federal Drug Administration has started sending warning letters to companies that boast their products can treat, diagnose, prevent, or cure COVID-19 or boost immunity.
The Federal Trade Commission (FTC) announced the agency is sending warning letters to companies that claim its products can treat or prevent coronavirus (COVID-19) due to lack of scientific evidence